These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28968877)

  • 1. A Persistent Hotspot of Schistosoma mansoni Infection in a Five-Year Randomized Trial of Praziquantel Preventative Chemotherapy Strategies.
    Wiegand RE; Mwinzi PNM; Montgomery SP; Chan YL; Andiego K; Omedo M; Muchiri G; Ogutu MO; Rawago F; Odiere MR; Karanja DMS; Secor WE
    J Infect Dis; 2017 Dec; 216(11):1425-1433. PubMed ID: 28968877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cluster randomized trial comparing school-based mass drug administration schedules in areas of western Kenya with moderate initial prevalence of Schistosoma mansoni infections.
    Karanja DMS; Awino EK; Wiegand RE; Okoth E; Abudho BO; Mwinzi PNM; Montgomery SP; Secor WE
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006033. PubMed ID: 29059190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of School-Based and Community-Wide Mass Drug Administration for Schistosomiasis Control in an Area of Western Kenya with High Initial
    Secor WE; Wiegand RE; Montgomery SP; Karanja DMS; Odiere MR
    Am J Trop Med Hyg; 2020 Feb; 102(2):318-327. PubMed ID: 31802733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High level of Schistosoma mansoni infection in pre-school children in Sierra Leone highlights the need in targeting this age group for praziquantel treatment.
    Hodges MH; Paye J; Koroma MM; Nyorkor ED; Fofonah I; Zhang Y
    Acta Trop; 2012 Nov; 124(2):120-5. PubMed ID: 22820025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of morbidity in Schistosoma mansoni-positive primary and secondary school children after four years of mass drug administration of praziquantel in western Kenya.
    Abudho BO; Guyah B; Ondigo BN; Ndombi EM; Ireri E; Carter JM; Riner DK; Kittur N; Karanja DMS; Colley DG
    Infect Dis Poverty; 2020 Jun; 9(1):67. PubMed ID: 32539826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustaining Control of Schistosomiasis Mansoni in Western Côte d'Ivoire: Results from a SCORE Study, One Year after Initial Praziquantel Administration.
    Assaré RK; Tian-Bi YN; Yao PK; N'Guessan NA; Ouattara M; Yapi A; Coulibaly JT; Meïté A; Hürlimann E; Knopp S; Utzinger J; N'Goran EK
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004329. PubMed ID: 26789749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of school-based preventive chemotherapy strategies for sustaining the control of schistosomiasis in Côte d'Ivoire: Results of a 5-year cluster randomized trial.
    Ouattara M; Diakité NR; Yao PK; Saric J; Coulibaly JT; Assaré RK; Bassa FK; Koné N; Guindo-Coulibaly N; Hattendorf J; Utzinger J; N'Goran EK
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008845. PubMed ID: 33449924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Four Years of Annual Mass Drug Administration on Prevalence and Intensity of Schistosomiasis among Primary and High School Children in Western Kenya: A Repeated Cross-Sectional Study.
    Abudho BO; Ndombi EM; Guya B; Carter JM; Riner DK; Kittur N; Karanja DMS; Secor WE; Colley DG
    Am J Trop Med Hyg; 2018 May; 98(5):1397-1402. PubMed ID: 29532768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Search for Snail-Related Answers to Explain Differences in Response of
    Mutuku MW; Laidemitt MR; Beechler BR; Mwangi IN; Otiato FO; Agola EL; Ochanda H; Kamel B; Mkoji GM; Steinauer ML; Loker ES
    Am J Trop Med Hyg; 2019 Jul; 101(1):65-77. PubMed ID: 31162012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling Approaches to Predicting Persistent Hotspots in SCORE Studies for Gaining Control of Schistosomiasis Mansoni in Kenya and Tanzania.
    Shen Y; Sung MH; King CH; Binder S; Kittur N; Whalen CC; Colley DG
    J Infect Dis; 2020 Feb; 221(5):796-803. PubMed ID: 31621850
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Sircar AD; Mwinzi PNM; Onkanga IO; Wiegand RE; Montgomery SP; Secor WE
    Am J Trop Med Hyg; 2018 Aug; 99(2):362-369. PubMed ID: 29893197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the performance of circulating cathodic antigen and Kato-Katz techniques in evaluating Schistosoma mansoni infection in areas with low prevalence in selected counties of Kenya: a cross-sectional study.
    Okoyo C; Simiyu E; Njenga SM; Mwandawiro C
    BMC Public Health; 2018 Apr; 18(1):478. PubMed ID: 29642875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Impact of Different Mass Drug Administration Strategies on Infection with
    Olsen A; Kinung'hi S; Magnussen P
    Am J Trop Med Hyg; 2018 Dec; 99(6):1573-1579. PubMed ID: 30350779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing teacher motivation and supervision is an important but not sufficient strategy for improving praziquantel uptake in Schistosoma mansoni control programs: serial cross sectional surveys in Uganda.
    Muhumuza S; Katahoire A; Nuwaha F; Olsen A
    BMC Infect Dis; 2013 Dec; 13():590. PubMed ID: 24330594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of two rounds of praziquantel mass drug administration on Schistosoma mansoni infection prevalence and intensity: a comparison between community wide treatment and school based treatment in western Kenya.
    Onkanga IO; Mwinzi PN; Muchiri G; Andiego K; Omedo M; Karanja DM; Wiegand RE; Secor WE; Montgomery SP
    Int J Parasitol; 2016 Jun; 46(7):439-45. PubMed ID: 26940547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential impact of mass and targeted praziquantel delivery on schistosomiasis control in school-aged children: A systematic review and meta-analysis.
    Cribb DM; Clarke NE; Doi SAR; Vaz Nery S
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007808. PubMed ID: 31603895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
    Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries.
    Shen Y; King CH; Binder S; Zhang F; Whalen CC; Evan Secor W; Montgomery SP; Mwinzi PNM; Olsen A; Magnussen P; Kinung'hi S; Phillips AE; Nalá R; Ferro J; Aurelio HO; Fleming F; Garba A; Hamidou A; Fenwick A; Campbell CH; Colley DG
    BMC Infect Dis; 2017 Sep; 17(1):652. PubMed ID: 28962552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rice irrigation and schistosomiasis in savannah and forest areas of Côte d'Ivoire.
    Yapi YG; Briët OJ; Diabate S; Vounatsou P; Akodo E; Tanner M; Teuscher T
    Acta Trop; 2005 Feb; 93(2):201-11. PubMed ID: 15652334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does mass drug administration affect Schistosoma mansoni infection trends in West Dembia district, Northwest Ethiopia?
    Zeleke AJ; Addisu A; Bayih AG; Tweya H; Timire C; Techilo W; Kamau EM; Vogt F; Verdonck K
    J Infect Dev Ctries; 2020 Jun; 14(6.1):72S-77S. PubMed ID: 32614800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.